drugset / Trial / NCT00000320

Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1

NCT00000320

Phase 1/2 Completed 120 enrolled National Institute on Drug Abuse (NIDA)
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to compare subject response to liquid vs. tablet formulations, to assess bioequivalency of liquid vs. tablet, to compare subject preference, and to evaluate if dose response curve for tablet is equal to liquid form."

Timeline

Start
1997-10
Primary completion
1999-08
Completion
1999-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Buprenorphine Other / unclassified